ACOR - Acorda Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts5555
Avg. Estimate-0.76-0.82-2.74-2.94
Low Estimate-0.81-1.02-2.94-3.29
High Estimate-0.71-0.67-2.55-2.66
Year Ago EPS0.170.452.18-2.74
Revenue EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts9999
Avg. Estimate43.23M40.56M180.22M158.62M
Low Estimate38.92M28.91M163.95M84.32M
High Estimate49M52M197.2M198.36M
Year Ago Sales142.81M69.15M471.43M180.22M
Sales Growth (year/est)-69.70%-41.30%-61.80%-12.00%
Earnings History9/29/201812/30/20183/30/20196/29/2019
EPS Est.-0.02-0.6-0.94-1.06
EPS Actual0.170.45-0.56-0.55
Difference0.191.050.380.51
Surprise %950.00%175.00%40.40%48.10%
EPS TrendCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.76-0.82-2.74-2.94
7 Days Ago-0.76-0.82-2.74-2.94
30 Days Ago-1.03-0.88-3.51-3.05
60 Days Ago-1.06-0.92-3.59-3.09
90 Days Ago-0.97-0.87-3.55-3.16
EPS RevisionsCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Up Last 7 Days3131
Up Last 30 Days8486
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days121N/A
Growth EstimatesACORIndustrySectorS&P 500
Current Qtr.-547.10%N/AN/A-0.00
Next Qtr.-282.20%N/AN/A0.08
Current Year-225.70%N/AN/A0.03
Next Year-7.30%N/AN/A0.10
Next 5 Years (per annum)29.00%N/AN/A0.08
Past 5 Years (per annum)19.85%N/AN/AN/A